Merck & Co., Inc. (NYSE:MRK)

Short Sellers Shy Away From Big Pharma

Posted: January 13, 2020 at 9:40 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Posted: January 6, 2020 at 12:45 pm
Last updated: January 7, 2020 12:51 pm

Now that 2019 has turned into 2020, it's important to reflect on the great stock market gains of 2019. It is even more important to try to figure out where ...
Read Full Story »

Is Pfizer Raising Drug Prices Too Much in 2020?

Posted: January 2, 2020 at 4:51 pm
Last updated: January 3, 2020 6:07 am

Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want ...
Read Full Story »

The Top Biopharma Events to Watch in 2020

Posted: January 2, 2020 at 10:25 am

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Big Pharma Short Sellers Get Selective

Posted: December 26, 2019 at 8:55 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The Top Biopharma Calendar Events to Watch Going Into 2020

Posted: December 23, 2019 at 11:00 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk and scrutiny with regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »

The First Ebola Vaccine Has Been Approved in the US

Posted: December 20, 2019 at 11:45 am

NewLink Genetics Corp. (NASDAQ: NLNK) and Merck & Co. Inc. (NYSE: MRK) shares made handy gains on Friday after it was announced that the U.S. Food and Drug Administration (FDA) ...
Read Full Story »

Meet the Preliminary 2020 Dogs of the Dow

Posted: December 13, 2019 at 12:25 pm

With 2019 coming to a rapid end, it's important to reflect on what happened in the past year. Still, it's more important to reflect on what 2020 will look like. ...
Read Full Story »

Big Pharma Short Sellers Grow More Selective

Posted: December 11, 2019 at 9:45 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted Dow Stocks

Posted: December 11, 2019 at 7:10 am

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

Why These 3 Biotechs More Than Doubled on Monday

Posted: December 9, 2019 at 10:40 am

Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Posted: November 27, 2019 at 9:00 am
Last updated: January 6, 2020 12:54 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Posted: November 18, 2019 at 10:50 am
Last updated: January 6, 2020 1:07 am

Investors love seeing the stock market hit new highs. It's impressive enough for the Dow Jones industrial average to have hit 28,000 and for the S&P 500 to have hit ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Posted: November 12, 2019 at 8:50 am
Last updated: January 6, 2020 1:17 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Posted: November 4, 2019 at 11:20 am
Last updated: January 6, 2020 1:29 am

When investors hear that the stock market just hit a new all-time high, it's probably fairly easy to assume that this means almost all the individual stocks are probably at ...
Read Full Story »